Mechanisms of glucocorticoid-mediated anti-inflammatory and immunosuppressive action

Paediatric and Perinatal Drug Therapy

Volumn 6, Issue 2, 2004, Pages 107-115

  Singh, Nikhil ^a   Rieder, Michael J ^a,b   Tucker, M Jane ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

Anti inflammatory; Cytokine; Glucocorticoids; Immunosuppression; T lymphocyte

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; CYTOKINE RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; I KAPPA B; IMMUNOSUPPRESSIVE AGENT; LEUCINE ZIPPER PROTEIN; LIPOCORTIN 1; NITRIC OXIDE;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CYTOKINE PRODUCTION; DRUG MECHANISM; EOSINOPHIL; GENE CONTROL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THYMOCYTE; TRANSCRIPTION REGULATION;

EID: 15944377423     PISSN: 14630095     EISSN: None     Source Type: Journal    
DOI: 10.1185/146300904X15106     Document Type: Review

References (83)

1. Beato M. Gene regulation by steroid hormones. Cell 1989;56:335-344.
2. Freedman LP. Anatomy of the steroid receptor zinc finger region. Endocr Rev 1992;13:129-145.
3. Kunicka JE, Talle MA, Denhardt GH et al. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 1993;149:39-49.
4. Tobler A, Meier R, Seitz M et al. Glucocorticoids downregulate gene expression of GM-CSF, NAP-I/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992;79:45-51.
5. Almawi WY, Saouda MS, Stevens AC et al. Partial mediation of glucocorticoid antiproliferative effects by lipocortins. J Immunol 1996;157:5231-5239.
6. AyanlarBatuman O, Ferrero AP, Diaz A, Jimenez SA. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes, J Clin Invest 1991;88:1574-1580.
7. Reyes-Moreno C, Frenette G, Boulanger J et al. Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells. Prostate 1995;26:260-269.
8. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992;89:9991-9995.
9. Tessier P, Audette M, Cattaruzzi P, McColl SR. Upregulation by tumor necrosis factor alpha of intercellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum 1993;1528-1539.
10. Druilhe A, Letuve S, Pretolani M, Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 2003;8:481-495.
11. Brunetti M, Martelli N, Colasante A et al. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes. Blood 1995; 86:4199-4205.
12. Owens GP, Hahn WE, Cohen JJ. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 1991;11: 4177-4188.
13. Vacchio MS, Ashwell JD. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J Exp Med 1997;185:2033-2038.
14. Tolosa E, King LB, Ashwell JD. Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice. Immunity 1998;8: 67-76.
15. Batuman OA, Ferrero AP, Diaz A, Berger B, Pomerantz RJ. Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells. Immunopharmacology 1994;27:43-55.
16. Baus E, Andris F, Dubois PM, Urbain J, Leo O. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol 1996;156:4555-4561.
17. Tobena R, Horikawa S, Calvo V, Alemany S. Interleukin-2 induces gamma-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activation. Biochem J 1996;319:929-933.
18. Agarwal SK, Marshall GD, Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 2001;21:147-155.
19. Ramierz F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996;156:2406-2412.
20. Crockard AD, Treacy MT, Droogan AG, McNeill TA, Hawkins SA. Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis. Mult Scler 1995;1:20-24.
21. Pitzalis C, Sharrack B, Gray IA, Lee A, Hughes RA. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis. J Neuroimmunol 1997;74:62-68.
22. Smith DR, Balashov KE, Hafler DA, Khoury SJ, Weiner HL. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia. Ann Neurol 1997;42:313-318.
23. Almawi WY, Hess DA, Assi JW, Chudzik DM, Rieder MJ. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999;8:637-647.
24. Franchimont D, Galon J, Vacchio MS et al. Positive effects of glucocorticoids on T cell function by upregulation of IL-7 receptor alpha. J Immunol 2002;168:2212-2218.
25. Lamas M, Sanz E, Martin-Parras L et al. Glucocorticoid hormones upregulate interleukin 2 receptor alpha gene expression. Cell Immunol 1993;151:437-450.
26. Brown DG, Sun XM, Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 1993;268:3037-3039.
27. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998;60:601-617.
28. Lanza L, Scudeletti M, Puppo F et al. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 1996;103:482-490.
29. Robbins RA, Barnes PJ, Springall DR et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994;203:209-218.
30. Almawi WY, Lipman ML, Stevens AC et al. Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. J Immunol 1991;146: 3523-3527.
31. Amano Y, Lee SW, Allison AC. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability. Mol Pharmacol 1993;43:176-182.
32. Blotta MH, DeKruyff RH, Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997;158:5589-5595.
33. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996;166:585-592.
34. Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987;139:4129-4134.
35. Krouwels FH, van der Heijden JF, Lutter R et al. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol 1996;14:388-397.
36. Monick MM, Aksamit TR, Geist LJ, Hunninghake GW. Dexamethasone inhibits IL-1 and TNF activity in human lung fibroblasts without affecting IL-1 or TNF receptors. Am J Physiol 1994;267:L33-L38.
37. Mori A, Kaminuma O, Suko M et al. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 1997;89:2891-2900.
38. Paliogianni F, Boumpas DT. Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human T lymphocytes. Transplantation 1995;59:1333-1339.
39. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992;77:494-499.
40. Yoshikawa H, Nakajima Y, Tasaka K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 1999;162:6162-6170.
41. Meyer T, Carlstedt-Duke J, Starr DB. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 1997;272:30709-30714.
42. Stromstedt PE, Poellinger L, Gustafsson JA, Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol 1991;11:3379-3383.
43. Almawi WY, Melemedjian OK. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 2002;71:9-15.
44. Berrebi D, Bruscoli S, Cohen N et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 2003;101:729-738.
45. Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 2001;276:29603-29610.
46. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14:452-460.
47. Konig H, Ponta H, Rahmsdorf HJ, Herrlich P. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992;11:2241-2246.
48. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995;270:286-290.
49. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS, Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-286.
50. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
51. Brostjan C, Anrather J, Csizmadia V et al. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996;271:19612-19616.
52. Heck S, Bender K, Kullmann M et al. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 1997; 16:4698-4707.
53. De Bosscher K, Schmitz ML, Vanden Berghe W et al. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 1997;94:13504-13509.
54. Blackwell GJ, Carnuccio R, Di Rosa M et al. Macrocortin: a polypeptide causing the antiphospholipase effect of glucocorticoids. Nature 1980;287:147-149.
55. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456-459.
56. Wallner BP, Mattaliano RJ, Hession C et al. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential antiinflammatory activity. Nature 1986;320:77-81.
57. Fessler BJ, Paliogianni F, Hama N, Balow JE, Boumpas DT. Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T cells: evidence for posttranscriptional regulation. Transplantation 1996;62:1113-1118.
58. Boumpas DT, Anastassiou ED, Older SA et al. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J Clin Invest 1991;87:1739-1747.
59. Brack A, Rittner HL, Younge BR et al. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99:2842-2850.
60. Boulanger J, Reyes-Moreno C, Koutsilieris M. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG-63 human osteosarcoma cells. Int J Cancer 1995;61:692-697.
61. Oursler MJ, Riggs BL, Spelsberg TC. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 1993;133:2187-2196.
62. Haynes AR, Shaw RJ. Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells. Am J Respir Cell Mol Biol 1992;7:198-206.
63. Peltier J, Perez J, Bellocq A et al. Transforming growth factor-beta 1 increases glucocorticoid binding and signaling in macrophages through a Smad- and activated protein-1-mediated process. Kidney Int 2003;63:2028-2036.
64. Jilma B, Voltmann J, Albinni S et al. Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther 1997;62:562-568.
65. Nakagawa M, Bondy GP, Waisman D et al. The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood 1999;93:2730-2737.
66. Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol 1996;167:79-85.
67. van de SA, Caldenhoven E, Raaijmakers JA, van der Saag PT, Koenderman L. Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 1993;8:340-347.
68. Menzel T, Luhrs H, Zirlik S et al. Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm Bowel Dis 2004;10:122-128.
69. Wilson SJ, Wallin A, Della-Cioppa G, Sandstrom T, Holgate ST. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001; 164:1047-1052.
70. Chen W, Lee JY, Hsieh WC. Effects of dexamethasone and sex hormones on cytokine-induced cellular adhesion molecule expression in human endothelial cells. Eur J Dermatol 2002;12:445-448.
71. Jilma B, Blann AD, Stohlawetz P et al. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men. J Lab Clin Med 2000; 135:270-274.
72. Park SK, Yang WS, Lee SK et al. TGF-beta(1) down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells. Nephrol Dial Transplant 2000;15:596-604.
73. Pitzalis C, Pipitone N, Bajocchi G et al. Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: an additional mechanism for their anti-inflammatory and immunosuppressive effect. J Immunol 1997;158:5007-5016.
74. Bianchi M, Meng C, Ivashkiv LB. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. Proc Natl Acad Sci U S A 2000;97:9573-9578.
75. Hu X, Li WP, Meng C, Ivashkiv LB. Inhibition of IFN-gamma signaling by glucocorticoids. J Immunol 2003;170:4833-4839.
76. Pelaia G, Cuda G, Vatrella A et al. Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol 2001;62:1719-1724.
77. Kassel O, Sancono A, Kratzschmar J et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 2001;20:7108-7116.
78. Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum 1998;41:761-767.
79. Pitzalis C, Pipitone N, Perretti M. Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 2002;966:108-118.
80. Manna SK, Aggarwal BB. Interleukin-4 downregulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13. J Biol Chem 1998;273:33333-33341.
81. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
82. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995;121-129.
83. Cogan E, Schandene L, Crusiaux A et al. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-538.